妊娠期乳腺癌的研究现状及进展  

Research status and progress of pregnancy-associated breast cancer

作　　者：刘杰娜 柳林[1] 梁文龙 陈晰[1] 沈滨[1] 张建国[1] Liu Jiena;Liu Lin;Liang Wenlong;Chen Xi;Shen Bin;Zhang Jianguo(Department of Breast Surgery,the Second Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150086,China)

机构地区：[1]哈尔滨医科大学附属第二医院乳腺外科

出　　处：《现代肿瘤医学》2020年第2期335-338,共4页Journal of Modern Oncology

基　　金：国家自然科学基金(编号:81372838)

摘　　要：妊娠期乳腺癌是指妊娠期间及分娩后1年内确诊的乳腺癌。妊娠期乳腺癌患者的临床预后与肿瘤的生物学特征及肿瘤分期相关,妊娠不是导致不良预后的独立危险因素。但妊娠期激素水平变化使得乳腺组织较为致密,妊娠期乳腺癌早期易被漏诊。由于许多诊断治疗方式可能影响胎儿的正常发育,妊娠增加了乳腺癌治疗方案制定的复杂性。妊娠期乳腺癌需多学科专家根据肿瘤生物学特征、肿瘤分期、孕周及患者和家属意愿等共同制定综合治疗策略。Breast cancer diagnosed during pregnancy and within one year after delivery is defined as pregnancy-associated breast cancer.Studies have shown that pregnancy-associated breast cancer does not improve the efficacy and prognosis of breast cancer due to termination of pregnancy.Pregnancy is not an independent risk factor leading to poor prognosis.Pregnancy-associated breast cancer is prone to missed diagnosis and treatment is complicated.Multidisciplinary experts are required to formulate comprehensive treatment strategies based on the biological characteristics of tumors,tumor stages,gestational weeks,and the wishes of patients and family members.

关 键 词：乳腺癌 妊娠 诊断 治疗 

分 类 号：R737.9[医药卫生—肿瘤]